Minocycline Hydrochloride Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 16 pharmaceutical companies such as NORVIUM BIOSCIENCE, BAUSCH, CHARTWELL RX and others. It is marketed under 7 brand names, including MINOCYCLINE HYDROCHLORIDE, SOLODYN, XIMINO and others. Available in 17 different strengths, such as EQ 135MG BASE, EQ 45MG BASE, EQ 90MG BASE and others, and administered through 6 routes including TABLET, EXTENDED RELEASE;ORAL, CAPSULE, EXTENDED RELEASE;ORAL, CAPSULE;ORAL and others.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 16 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"44980","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"SOLODYN","family_id":"deea42e8a5af4d91970d","publication_number":"US7790705B2","cleaned_patent_number":"7790705","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-06-24","publication_date":"2010-09-07","legal_status":"Granted"} US7790705B2 07 Sep, 2010 Granted 24 Jun, 2025
{"application_id":"44983","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"SOLODYN","family_id":"deea42e8a5af4d91970d","publication_number":"US8722650B1","cleaned_patent_number":"8722650","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-06-24","publication_date":"2014-05-13","legal_status":"Granted"} US8722650B2 13 May, 2014 Granted 24 Jun, 2025
{"application_id":"44982","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"SOLODYN","family_id":"deea42e8a5af4d91970d","publication_number":"US8252776B2","cleaned_patent_number":"8252776","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-06-24","publication_date":"2012-08-28","legal_status":"Granted"} US8252776B2 28 Aug, 2012 Granted 24 Jun, 2025
{"application_id":"44968","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"SOLODYN","family_id":"deea42e8a5af4d91970d","publication_number":"US8268804B2","cleaned_patent_number":"8268804","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-06-24","publication_date":"2012-09-18","legal_status":"Granted"} US8268804B2 18 Sep, 2012 Granted 24 Jun, 2025
{"application_id":"44981","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"SOLODYN","family_id":"deea42e8a5af4d91970d","publication_number":"US7919483B2","cleaned_patent_number":"7919483","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-03-07","publication_date":"2011-04-05","legal_status":"Granted"} US7919483B2 05 Apr, 2011 Granted 07 Mar, 2027
{"application_id":"44979","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"SOLODYN","family_id":"deea42e8a5af4d91970d","publication_number":"US7544373B2","cleaned_patent_number":"7544373","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-04-02","publication_date":"2009-06-09","legal_status":"Granted"} US7544373B2 Formulation 09 Jun, 2009 Granted 02 Apr, 2027
{"application_id":"44978","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"SOLODYN","family_id":"deea42e8a5af4d91970d","publication_number":"US7541347B2","cleaned_patent_number":"7541347","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-04-02","publication_date":"2009-06-02","legal_status":"Granted"} US7541347B2 02 Jun, 2009 Granted 02 Apr, 2027
{"application_id":"42646","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"ZILXI","family_id":"d6834898829946cebcd0","publication_number":"US10946101B2","cleaned_patent_number":"10946101","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-10-01","publication_date":"2021-03-16","legal_status":"Granted"} US10946101B2 16 Mar, 2021 Granted 01 Oct, 2030
{"application_id":"42656","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"ZILXI","family_id":"d6834898829946cebcd0","publication_number":"US20200261586A1","cleaned_patent_number":"12138311","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-10-01","publication_date":"2024-11-12","legal_status":"Granted"} US12138311B2 12 Nov, 2024 Granted 01 Oct, 2030
{"application_id":"42633","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"AMZEEQ","family_id":"d6834898829946cebcd0","publication_number":"US9675700B2","cleaned_patent_number":"9675700","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-10-01","publication_date":"2017-06-13","legal_status":"Granted"} US9675700B2 Formulation 13 Jun, 2017 Granted 01 Oct, 2030
{"application_id":"42608","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"AMZEEQ","family_id":"d6834898829946cebcd0","publication_number":"US10137200B2","cleaned_patent_number":"10137200","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-10-01","publication_date":"2018-11-27","legal_status":"Expired"} US10137200B2 27 Nov, 2018 Expired 01 Oct, 2030
{"application_id":"42637","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"AMZEEQ","family_id":"d6834898829946cebcd0","publication_number":"US10213512B2","cleaned_patent_number":"10213512","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-10-01","publication_date":"2019-02-26","legal_status":"Expired"} US10213512B2 Formulation 26 Feb, 2019 Expired 01 Oct, 2030
{"application_id":"42639","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"AMZEEQ","family_id":"d6834898829946cebcd0","publication_number":"US10265404B2","cleaned_patent_number":"10265404","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-10-01","publication_date":"2019-04-23","legal_status":"Granted"} US10265404B2 Formulation 23 Apr, 2019 Granted 01 Oct, 2030
{"application_id":"42640","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"ZILXI","family_id":"d6834898829946cebcd0","publication_number":"US10322186B2","cleaned_patent_number":"10322186","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-10-01","publication_date":"2019-06-18","legal_status":"Granted"} US10322186B2 18 Jun, 2019 Granted 01 Oct, 2030
{"application_id":"42642","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"AMZEEQ","family_id":"d6834898829946cebcd0","publication_number":"US10517882B2","cleaned_patent_number":"10517882","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-10-01","publication_date":"2019-12-31","legal_status":"Patented case"} US10517882B2 31 Dec, 2019 Patented case 01 Oct, 2030
{"application_id":"42644","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"AMZEEQ","family_id":"d6834898829946cebcd0","publication_number":"US10821187B2","cleaned_patent_number":"10821187","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-10-01","publication_date":"2020-11-03","legal_status":"Granted"} US10821187B2 03 Nov, 2020 Granted 01 Oct, 2030
{"application_id":"42685","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"AMZEEQ","family_id":"d6834898829946cebcd0","publication_number":"US8865139B1","cleaned_patent_number":"8865139","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-10-01","publication_date":"2014-10-21","legal_status":"Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362"} US8865139B2 Formulation 21 Oct, 2014 Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362 01 Oct, 2030
{"application_id":"42631","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"AMZEEQ","family_id":"d6834898829946cebcd0","publication_number":"US8945516B2","cleaned_patent_number":"8945516","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-10-01","publication_date":"2015-02-03","legal_status":"Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362"} US8945516B2 Formulation 03 Feb, 2015 Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362 01 Oct, 2030
{"application_id":"42632","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"AMZEEQ","family_id":"d6834898829946cebcd0","publication_number":"US8992896B2","cleaned_patent_number":"8992896","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-10-01","publication_date":"2015-03-31","legal_status":"Patented case"} US8992896B2 Formulation 31 Mar, 2015 Patented case 01 Oct, 2030
{"application_id":"42636","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"AMZEEQ","family_id":"d6834898829946cebcd0","publication_number":"US10086080B2","cleaned_patent_number":"10086080","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-10-01","publication_date":"2018-10-02","legal_status":"Expired"} US10086080B2 02 Oct, 2018 Expired 01 Oct, 2030
{"application_id":"139376","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"MINOCIN","family_id":"fde4253809f14b808b63","publication_number":"US12161656B2","cleaned_patent_number":"12161656","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-12","publication_date":"2024-12-10","legal_status":"Granted"} US12161656B2 Formulation 10 Dec, 2024 Granted 12 May, 2031
{"application_id":"61888","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"MINOCIN","family_id":"fde4253809f14b808b63","publication_number":"US9278105B2","cleaned_patent_number":"9278105","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-12","publication_date":"2016-03-08","legal_status":"Granted"} US9278105B2 08 Mar, 2016 Granted 12 May, 2031
{"application_id":"61864","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"MINOCIN","family_id":"fde4253809f14b808b63","publication_number":"US9084802B2","cleaned_patent_number":"9084802","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-12","publication_date":"2015-07-21","legal_status":"Granted"} US9084802B2 21 Jul, 2015 Granted 12 May, 2031
{"application_id":"44984","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"SOLODYN","family_id":"deea42e8a5af4d91970d","publication_number":"US9192615B2","cleaned_patent_number":"9192615","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-11-17","publication_date":"2015-11-24","legal_status":"Granted"} US9192615B2 Formulation 24 Nov, 2015 Granted 17 Nov, 2031
{"application_id":"61891","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"MINOCIN","family_id":"fde4253809f14b808b63","publication_number":"US11944634B2","cleaned_patent_number":"11944634","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-10-16","publication_date":"2024-04-02","legal_status":"Granted"} US11944634B2 Formulation 02 Apr, 2024 Granted 16 Oct, 2032
{"application_id":"86409","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"MINOLIRA","family_id":"2a7b557e9d514fb980c7","publication_number":"US11103517B2","cleaned_patent_number":"11103517","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-07","publication_date":"2021-08-31","legal_status":"Granted"} US11103517B2 Formulation 31 Aug, 2021 Granted 07 Apr, 2036
{"application_id":"42686","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"AMZEEQ","family_id":"9ed7fc48588f41ae9764","publication_number":"US10398641B2","cleaned_patent_number":"10398641","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-09-08","publication_date":"2019-09-03","legal_status":"Granted"} US10398641B2 03 Sep, 2019 Granted 08 Sep, 2037
{"application_id":"42689","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"AMZEEQ","family_id":"9ed7fc48588f41ae9764","publication_number":"US10849847B2","cleaned_patent_number":"10849847","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-09-08","publication_date":"2020-12-01","legal_status":"Granted"} US10849847B2 01 Dec, 2020 Granted 08 Sep, 2037
{"application_id":"138431","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"EMROSI","family_id":"","publication_number":"US10905664B2","cleaned_patent_number":"10905664","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-01-07","publication_date":"2021-02-02","legal_status":"Granted"} US10905664B2 02 Feb, 2021 Granted 07 Jan, 2039
{"application_id":"138429","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"EMROSI","family_id":"","publication_number":"US11364212B2","cleaned_patent_number":"11364212","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-01-07","publication_date":"2022-06-21","legal_status":"Granted"} US11364212B2 21 Jun, 2022 Granted 07 Jan, 2039
{"application_id":"138430","ingredient":"MINOCYCLINE HYDROCHLORIDE","trade_name":"EMROSI","family_id":"","publication_number":"US11191740B2","cleaned_patent_number":"11191740","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-01-07","publication_date":"2021-12-07","legal_status":"Patented Case"} US11191740B2 07 Dec, 2021 Patented Case 07 Jan, 2039

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Minocycline Hydrochloride

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.